Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours ยท Estimated delivery Oct 30 - Nov 4
B12 deficiency is present in close to 50% of people over 60 years of age
medical or diagnostic use
it was studied by Novo Nordisk and later Helsinn Therapeutics, including a Phase II trial for postoperative ileus, but development was discontinued for lack of efficacy
However, this approach is not routine first-line treatment in UK practice, is considered off-label, and requires good patient adherence and clinical follow-up
Reporting suspected adverse reactions : If you experience a suspected side effect from an unlicensed product, please report it via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk)
ClinicalTrials.gov ID: NCT05740722
US$ 22.74
US$ 28.32
US$ 23.92
US$ 27.59
